Osteoporosis is a silent disease that often remains asymptomatic and u
ndetected until bone fracture occurs. Because of the high morbidity as
sociated with fracture, prevention is a clinical priority. In order to
identify those who would benefit from therapeutic intervention, bone
density measurement is indicated in patients with risk factors for ost
eoporosis. Therapies include hormone replacement, calcitonin, bisphosp
honates, and selective estrogen receptor modulators, as well as exerci
se and supplements of calcium and vitamin D. The goal of all treatment
s is to decrease the risk of fracture by minimizing bone loss and incr
easing bone mass.